Kathryn Lang is a highly experienced professional in the field of hematology-oncology, currently serving as a Scientific Advisory Board Member at Karius since January 2023. Prior roles include Senior Vice President of Data & Digital at Freenome and Senior Vice President of Clinical at Paradigm, along with Vice President of Outcomes and Evidence at Guardant Health. Kathryn Lang has also held significant positions at Pfizer, including Global Head of Oncology Real-World Evidence and Medical Lead in Hematology. Before transitioning to industry, Kathryn Lang worked as a physician specialized in hematology-oncology within the NHS. Educational credentials include a Bachelor of Medicine and Bachelor of Surgery from Newcastle University, an MRCP(UK) from the Royal College of Physicians, an MRes in Epidemiological Design and Analysis from Erasmus University Rotterdam, and an FRCPath in Hematology from the Royal College of Pathology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices